0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Particle Engineering Service Market Research Report 2026
Published Date: 2026-01-21
|
Report Code: QYRE-Auto-20I18986
Home | Market Reports | Science
Global Drug Particle Engineering Service Market Research Report 2025
BUY CHAPTERS

Global Drug Particle Engineering Service Market Research Report 2026

Code: QYRE-Auto-20I18986
Report
2026-01-21
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Particle Engineering Service Market Size

The global Drug Particle Engineering Service market was valued at US$ 1226 million in 2025 and is anticipated to reach US$ 1639 million by 2032, at a CAGR of 4.3% from 2026 to 2032.

Drug Particle Engineering Service Market

Drug Particle Engineering Service Market

Drug particle engineering service is a comprehensive service that provides particle design, preparation, characterization, and optimization services for drug development and production. This service aims to improve the physical properties of drugs, increase their solubility and bioavailability, and thereby enhance their efficacy and safety through advanced particle engineering techniques. Drug Particle Engineering Service covers the entire process from the design and preparation of drug particles to their characterization and optimization, including the regulation of particle size, shape, and surface properties. Through this service, customers can obtain drug products with specific particle characteristics to meet their needs for new drug development and production. Additionally, this service provides professional technical support and solutions to help customers solve particle-related issues encountered during drug development and production.
The North American market for Drug Particle Engineering Service is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Drug Particle Engineering Service is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Drug Particle Engineering Service in Oral Medications is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Drug Particle Engineering Service include Lonza, CritiTech, EUROAPI, Schedio, Solid State Pharma, Hovione, Evonik, Balchem, AP-Process, Micromeritics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Drug Particle Engineering Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drug Particle Engineering Service. The Drug Particle Engineering Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Drug Particle Engineering Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drug Particle Engineering Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Drug Particle Engineering Service Market Report

Report Metric Details
Report Name Drug Particle Engineering Service Market
Accounted market size in 2025 US$ 1226 million
Forecasted market size in 2032 US$ 1639 million
CAGR 4.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Standard Drug Particle Engineering Service
  • Customized Drug Particle Engineering Service
Segment by Application
  • Oral Medications
  • Parenteral Medications
  • Inhaled Medications
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza, CritiTech, EUROAPI, Schedio, Solid State Pharma, Hovione, Evonik, Balchem, AP-Process, Micromeritics, Wuxi AppTec, Xedev, Munit
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Drug Particle Engineering Service companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Drug Particle Engineering Service Market growing?

Ans: The Drug Particle Engineering Service Market witnessing a CAGR of 4.3% during the forecast period 2026-2032.

What is the Drug Particle Engineering Service Market size in 2032?

Ans: The Drug Particle Engineering Service Market size in 2032 will be US$ 1639 million.

Who are the main players in the Drug Particle Engineering Service Market report?

Ans: The main players in the Drug Particle Engineering Service Market are Lonza, CritiTech, EUROAPI, Schedio, Solid State Pharma, Hovione, Evonik, Balchem, AP-Process, Micromeritics, Wuxi AppTec, Xedev, Munit

What are the Application segmentation covered in the Drug Particle Engineering Service Market report?

Ans: The Applications covered in the Drug Particle Engineering Service Market report are Oral Medications, Parenteral Medications, Inhaled Medications, Others

What are the Type segmentation covered in the Drug Particle Engineering Service Market report?

Ans: The Types covered in the Drug Particle Engineering Service Market report are Standard Drug Particle Engineering Service, Customized Drug Particle Engineering Service

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Particle Engineering Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Standard Drug Particle Engineering Service
1.2.3 Customized Drug Particle Engineering Service
1.3 Market by Application
1.3.1 Global Drug Particle Engineering Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Oral Medications
1.3.3 Parenteral Medications
1.3.4 Inhaled Medications
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Particle Engineering Service Market Perspective (2021–2032)
2.2 Global Drug Particle Engineering Service Growth Trends by Region
2.2.1 Global Drug Particle Engineering Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Drug Particle Engineering Service Historic Market Size by Region (2021–2026)
2.2.3 Drug Particle Engineering Service Forecasted Market Size by Region (2027–2032)
2.3 Drug Particle Engineering Service Market Dynamics
2.3.1 Drug Particle Engineering Service Industry Trends
2.3.2 Drug Particle Engineering Service Market Drivers
2.3.3 Drug Particle Engineering Service Market Challenges
2.3.4 Drug Particle Engineering Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Particle Engineering Service Players by Revenue
3.1.1 Global Top Drug Particle Engineering Service Players by Revenue (2021–2026)
3.1.2 Global Drug Particle Engineering Service Revenue Market Share by Players (2021–2026)
3.2 Global Top Drug Particle Engineering Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Drug Particle Engineering Service Revenue
3.4 Global Drug Particle Engineering Service Market Concentration Ratio
3.4.1 Global Drug Particle Engineering Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Particle Engineering Service Revenue in 2025
3.5 Global Key Players of Drug Particle Engineering Service Head Offices and Areas Served
3.6 Global Key Players of Drug Particle Engineering Service, Products and Applications
3.7 Global Key Players of Drug Particle Engineering Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Drug Particle Engineering Service Breakdown Data by Type
4.1 Global Drug Particle Engineering Service Historic Market Size by Type (2021–2026)
4.2 Global Drug Particle Engineering Service Forecasted Market Size by Type (2027–2032)
5 Drug Particle Engineering Service Breakdown Data by Application
5.1 Global Drug Particle Engineering Service Historic Market Size by Application (2021–2026)
5.2 Global Drug Particle Engineering Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Drug Particle Engineering Service Market Size (2021–2032)
6.2 North America Drug Particle Engineering Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Drug Particle Engineering Service Market Size by Country (2021–2026)
6.4 North America Drug Particle Engineering Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Particle Engineering Service Market Size (2021–2032)
7.2 Europe Drug Particle Engineering Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Drug Particle Engineering Service Market Size by Country (2021–2026)
7.4 Europe Drug Particle Engineering Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Drug Particle Engineering Service Market Size (2021–2032)
8.2 Asia-Pacific Drug Particle Engineering Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Drug Particle Engineering Service Market Size by Region (2021–2026)
8.4 Asia-Pacific Drug Particle Engineering Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Drug Particle Engineering Service Market Size (2021–2032)
9.2 Latin America Drug Particle Engineering Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Drug Particle Engineering Service Market Size by Country (2021–2026)
9.4 Latin America Drug Particle Engineering Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Particle Engineering Service Market Size (2021–2032)
10.2 Middle East & Africa Drug Particle Engineering Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Drug Particle Engineering Service Market Size by Country (2021–2026)
10.4 Middle East & Africa Drug Particle Engineering Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Drug Particle Engineering Service Introduction
11.1.4 Lonza Revenue in Drug Particle Engineering Service Business (2021–2026)
11.1.5 Lonza Recent Development
11.2 CritiTech
11.2.1 CritiTech Company Details
11.2.2 CritiTech Business Overview
11.2.3 CritiTech Drug Particle Engineering Service Introduction
11.2.4 CritiTech Revenue in Drug Particle Engineering Service Business (2021–2026)
11.2.5 CritiTech Recent Development
11.3 EUROAPI
11.3.1 EUROAPI Company Details
11.3.2 EUROAPI Business Overview
11.3.3 EUROAPI Drug Particle Engineering Service Introduction
11.3.4 EUROAPI Revenue in Drug Particle Engineering Service Business (2021–2026)
11.3.5 EUROAPI Recent Development
11.4 Schedio
11.4.1 Schedio Company Details
11.4.2 Schedio Business Overview
11.4.3 Schedio Drug Particle Engineering Service Introduction
11.4.4 Schedio Revenue in Drug Particle Engineering Service Business (2021–2026)
11.4.5 Schedio Recent Development
11.5 Solid State Pharma
11.5.1 Solid State Pharma Company Details
11.5.2 Solid State Pharma Business Overview
11.5.3 Solid State Pharma Drug Particle Engineering Service Introduction
11.5.4 Solid State Pharma Revenue in Drug Particle Engineering Service Business (2021–2026)
11.5.5 Solid State Pharma Recent Development
11.6 Hovione
11.6.1 Hovione Company Details
11.6.2 Hovione Business Overview
11.6.3 Hovione Drug Particle Engineering Service Introduction
11.6.4 Hovione Revenue in Drug Particle Engineering Service Business (2021–2026)
11.6.5 Hovione Recent Development
11.7 Evonik
11.7.1 Evonik Company Details
11.7.2 Evonik Business Overview
11.7.3 Evonik Drug Particle Engineering Service Introduction
11.7.4 Evonik Revenue in Drug Particle Engineering Service Business (2021–2026)
11.7.5 Evonik Recent Development
11.8 Balchem
11.8.1 Balchem Company Details
11.8.2 Balchem Business Overview
11.8.3 Balchem Drug Particle Engineering Service Introduction
11.8.4 Balchem Revenue in Drug Particle Engineering Service Business (2021–2026)
11.8.5 Balchem Recent Development
11.9 AP-Process
11.9.1 AP-Process Company Details
11.9.2 AP-Process Business Overview
11.9.3 AP-Process Drug Particle Engineering Service Introduction
11.9.4 AP-Process Revenue in Drug Particle Engineering Service Business (2021–2026)
11.9.5 AP-Process Recent Development
11.10 Micromeritics
11.10.1 Micromeritics Company Details
11.10.2 Micromeritics Business Overview
11.10.3 Micromeritics Drug Particle Engineering Service Introduction
11.10.4 Micromeritics Revenue in Drug Particle Engineering Service Business (2021–2026)
11.10.5 Micromeritics Recent Development
11.11 Wuxi AppTec
11.11.1 Wuxi AppTec Company Details
11.11.2 Wuxi AppTec Business Overview
11.11.3 Wuxi AppTec Drug Particle Engineering Service Introduction
11.11.4 Wuxi AppTec Revenue in Drug Particle Engineering Service Business (2021–2026)
11.11.5 Wuxi AppTec Recent Development
11.12 Xedev
11.12.1 Xedev Company Details
11.12.2 Xedev Business Overview
11.12.3 Xedev Drug Particle Engineering Service Introduction
11.12.4 Xedev Revenue in Drug Particle Engineering Service Business (2021–2026)
11.12.5 Xedev Recent Development
11.13 Munit
11.13.1 Munit Company Details
11.13.2 Munit Business Overview
11.13.3 Munit Drug Particle Engineering Service Introduction
11.13.4 Munit Revenue in Drug Particle Engineering Service Business (2021–2026)
11.13.5 Munit Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Drug Particle Engineering Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Standard Drug Particle Engineering Service
 Table 3. Key Players of Customized Drug Particle Engineering Service
 Table 4. Global Drug Particle Engineering Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Drug Particle Engineering Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Drug Particle Engineering Service Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Drug Particle Engineering Service Market Share by Region (2021–2026)
 Table 8. Global Drug Particle Engineering Service Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Drug Particle Engineering Service Market Share by Region (2027–2032)
 Table 10. Drug Particle Engineering Service Market Trends
 Table 11. Drug Particle Engineering Service Market Drivers
 Table 12. Drug Particle Engineering Service Market Challenges
 Table 13. Drug Particle Engineering Service Market Restraints
 Table 14. Global Drug Particle Engineering Service Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Drug Particle Engineering Service Market Share by Players (2021–2026)
 Table 16. Global Top Drug Particle Engineering Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Drug Particle Engineering Service Revenue, 2025
 Table 17. Ranking of Global Top Drug Particle Engineering Service Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Drug Particle Engineering Service Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Drug Particle Engineering Service, Headquarters and Area Served
 Table 20. Global Key Players of Drug Particle Engineering Service, Products and Applications
 Table 21. Global Key Players of Drug Particle Engineering Service, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Drug Particle Engineering Service Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Drug Particle Engineering Service Revenue Market Share by Type (2021–2026)
 Table 25. Global Drug Particle Engineering Service Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Drug Particle Engineering Service Revenue Market Share by Type (2027–2032)
 Table 27. Global Drug Particle Engineering Service Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Drug Particle Engineering Service Revenue Market Share by Application (2021–2026)
 Table 29. Global Drug Particle Engineering Service Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Drug Particle Engineering Service Revenue Market Share by Application (2027–2032)
 Table 31. North America Drug Particle Engineering Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Drug Particle Engineering Service Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Drug Particle Engineering Service Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Drug Particle Engineering Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Drug Particle Engineering Service Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Drug Particle Engineering Service Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Drug Particle Engineering Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Drug Particle Engineering Service Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Drug Particle Engineering Service Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Drug Particle Engineering Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Drug Particle Engineering Service Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Drug Particle Engineering Service Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Drug Particle Engineering Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Drug Particle Engineering Service Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Drug Particle Engineering Service Market Size by Country (US$ Million), 2027–2032
 Table 46. Lonza Company Details
 Table 47. Lonza Business Overview
 Table 48. Lonza Drug Particle Engineering Service Product
 Table 49. Lonza Revenue in Drug Particle Engineering Service Business (US$ Million), 2021–2026
 Table 50. Lonza Recent Development
 Table 51. CritiTech Company Details
 Table 52. CritiTech Business Overview
 Table 53. CritiTech Drug Particle Engineering Service Product
 Table 54. CritiTech Revenue in Drug Particle Engineering Service Business (US$ Million), 2021–2026
 Table 55. CritiTech Recent Development
 Table 56. EUROAPI Company Details
 Table 57. EUROAPI Business Overview
 Table 58. EUROAPI Drug Particle Engineering Service Product
 Table 59. EUROAPI Revenue in Drug Particle Engineering Service Business (US$ Million), 2021–2026
 Table 60. EUROAPI Recent Development
 Table 61. Schedio Company Details
 Table 62. Schedio Business Overview
 Table 63. Schedio Drug Particle Engineering Service Product
 Table 64. Schedio Revenue in Drug Particle Engineering Service Business (US$ Million), 2021–2026
 Table 65. Schedio Recent Development
 Table 66. Solid State Pharma Company Details
 Table 67. Solid State Pharma Business Overview
 Table 68. Solid State Pharma Drug Particle Engineering Service Product
 Table 69. Solid State Pharma Revenue in Drug Particle Engineering Service Business (US$ Million), 2021–2026
 Table 70. Solid State Pharma Recent Development
 Table 71. Hovione Company Details
 Table 72. Hovione Business Overview
 Table 73. Hovione Drug Particle Engineering Service Product
 Table 74. Hovione Revenue in Drug Particle Engineering Service Business (US$ Million), 2021–2026
 Table 75. Hovione Recent Development
 Table 76. Evonik Company Details
 Table 77. Evonik Business Overview
 Table 78. Evonik Drug Particle Engineering Service Product
 Table 79. Evonik Revenue in Drug Particle Engineering Service Business (US$ Million), 2021–2026
 Table 80. Evonik Recent Development
 Table 81. Balchem Company Details
 Table 82. Balchem Business Overview
 Table 83. Balchem Drug Particle Engineering Service Product
 Table 84. Balchem Revenue in Drug Particle Engineering Service Business (US$ Million), 2021–2026
 Table 85. Balchem Recent Development
 Table 86. AP-Process Company Details
 Table 87. AP-Process Business Overview
 Table 88. AP-Process Drug Particle Engineering Service Product
 Table 89. AP-Process Revenue in Drug Particle Engineering Service Business (US$ Million), 2021–2026
 Table 90. AP-Process Recent Development
 Table 91. Micromeritics Company Details
 Table 92. Micromeritics Business Overview
 Table 93. Micromeritics Drug Particle Engineering Service Product
 Table 94. Micromeritics Revenue in Drug Particle Engineering Service Business (US$ Million), 2021–2026
 Table 95. Micromeritics Recent Development
 Table 96. Wuxi AppTec Company Details
 Table 97. Wuxi AppTec Business Overview
 Table 98. Wuxi AppTec Drug Particle Engineering Service Product
 Table 99. Wuxi AppTec Revenue in Drug Particle Engineering Service Business (US$ Million), 2021–2026
 Table 100. Wuxi AppTec Recent Development
 Table 101. Xedev Company Details
 Table 102. Xedev Business Overview
 Table 103. Xedev Drug Particle Engineering Service Product
 Table 104. Xedev Revenue in Drug Particle Engineering Service Business (US$ Million), 2021–2026
 Table 105. Xedev Recent Development
 Table 106. Munit Company Details
 Table 107. Munit Business Overview
 Table 108. Munit Drug Particle Engineering Service Product
 Table 109. Munit Revenue in Drug Particle Engineering Service Business (US$ Million), 2021–2026
 Table 110. Munit Recent Development
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources
 Table 114. Authors List of This Report


List of Figures
 Figure 1. Drug Particle Engineering Service Picture
 Figure 2. Global Drug Particle Engineering Service Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Drug Particle Engineering Service Market Share by Type: 2025 vs 2032
 Figure 4. Standard Drug Particle Engineering Service Features
 Figure 5. Customized Drug Particle Engineering Service Features
 Figure 6. Global Drug Particle Engineering Service Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Drug Particle Engineering Service Market Share by Application: 2025 vs 2032
 Figure 8. Oral Medications Case Studies
 Figure 9. Parenteral Medications Case Studies
 Figure 10. Inhaled Medications Case Studies
 Figure 11. Others Case Studies
 Figure 12. Drug Particle Engineering Service Report Years Considered
 Figure 13. Global Drug Particle Engineering Service Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Drug Particle Engineering Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Drug Particle Engineering Service Market Share by Region: 2025 vs 2032
 Figure 16. Global Drug Particle Engineering Service Market Share by Players in 2025
 Figure 17. Global Drug Particle Engineering Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Drug Particle Engineering Service Revenue in 2025
 Figure 19. North America Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Drug Particle Engineering Service Market Share by Country (2021–2032)
 Figure 21. United States Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Drug Particle Engineering Service Market Share by Country (2021–2032)
 Figure 25. Germany Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Drug Particle Engineering Service Market Share by Region (2021–2032)
 Figure 33. China Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Drug Particle Engineering Service Market Share by Country (2021–2032)
 Figure 41. Mexico Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Drug Particle Engineering Service Market Share by Country (2021–2032)
 Figure 45. Israel Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Drug Particle Engineering Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Lonza Revenue Growth Rate in Drug Particle Engineering Service Business (2021–2026)
 Figure 49. CritiTech Revenue Growth Rate in Drug Particle Engineering Service Business (2021–2026)
 Figure 50. EUROAPI Revenue Growth Rate in Drug Particle Engineering Service Business (2021–2026)
 Figure 51. Schedio Revenue Growth Rate in Drug Particle Engineering Service Business (2021–2026)
 Figure 52. Solid State Pharma Revenue Growth Rate in Drug Particle Engineering Service Business (2021–2026)
 Figure 53. Hovione Revenue Growth Rate in Drug Particle Engineering Service Business (2021–2026)
 Figure 54. Evonik Revenue Growth Rate in Drug Particle Engineering Service Business (2021–2026)
 Figure 55. Balchem Revenue Growth Rate in Drug Particle Engineering Service Business (2021–2026)
 Figure 56. AP-Process Revenue Growth Rate in Drug Particle Engineering Service Business (2021–2026)
 Figure 57. Micromeritics Revenue Growth Rate in Drug Particle Engineering Service Business (2021–2026)
 Figure 58. Wuxi AppTec Revenue Growth Rate in Drug Particle Engineering Service Business (2021–2026)
 Figure 59. Xedev Revenue Growth Rate in Drug Particle Engineering Service Business (2021–2026)
 Figure 60. Munit Revenue Growth Rate in Drug Particle Engineering Service Business (2021–2026)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS